- Home
- NRXP vs APUR Comparison
NRXP vs APUR Comparison
Compare NRXP & APUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.47
Company Overview
Basic Information| Metric | NRXP | APUR |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.1M | 146.9M |
| IPO Year | 2017 | 2025 |
Fundamental Metrics
Financial Performance| Metric | NRXP | APUR |
|---|---|---|
| Price | $3.47 | $10.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $38.25 | N/A |
| AVG Volume (30 Days) | ★ 790.1K | 104.5K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 69.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,225,000.00 | N/A |
| Revenue This Year | $2,547.84 | N/A |
| Revenue Next Year | $1,591.73 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.65 | $9.90 |
| 52 Week High | $5.06 | $10.02 |
Technical Indicators
Market Signals| Indicator | NRXP | APUR |
|---|---|---|
| Relative Strength Index (RSI) | 49.32 | 81.29 |
| Support Level | $3.45 | $9.90 |
| Resistance Level | $3.62 | N/A |
| Average True Range (ATR) | 0.17 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 46.67 | 100.00 |
Price Performance
Historical Comparison NRXP
APUR
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About APUR Aperture AC Class A Ordinary Shares
Aperture AC is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.